Action APDN APPLIED DNA SCIENCES, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Applied DNA Sciences, Inc.

Actions

APDN

US03815U4094

Marché Fermé - Nasdaq
Autres places de cotation
 22:30:00 15/07/2024 		Varia. 5j. Varia. 1 janv.
0,4283 USD -1,06 % Graphique intraday de Applied DNA Sciences, Inc. +0,66 % -96,53 %
20/06 Applied DNA Sciences, Inc. et Alphazyme LLC concluent le projet de mise à l'échelle de la fabrication des RNAP de Linea (TM) et apportent une amélioration substantielle à l'économie de la plateforme IVT de Linea (TM) CI
18/06 Applied DNA s'associe à GenXys pour les tests pharmacogénétiques MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Applied DNA and Alphazyme Conclude Linea RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea IVT Platform Economics
Applied DNA Sciences, Inc. and Alphazyme LLC Conclude Linea (TM) RNAP Manufacturing Scale-Up Project, Deliver Substantial Improvement in Linea (TM) IVT Platform Economics
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic Testing
Applied DNA Partners With GenXys For Pharmacogenetic Testing
Applied DNA Sciences : Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
Applied DNA Sciences, Inc. Receives Approval for TR8(TM) Pharmacogenomic Testing Service from New York State Department of Health
Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea IVT Platform
Applied DNA Announces Pricing of $12 Million Public Offering
Applied DNA Sciences May Seek Potential Acquisitions
US Equities Markets Close Mixed Tuesday as Nvidia Propels Nasdaq to Record High
Top Midday Decliners
Applied DNA Sciences Prices $12 Million Public Offering of Units
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement
Top Premarket Decliners
Applied DNA Sciences: Fiscal Q2 Earnings Snapshot
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q2 Revenue $929,631
Applied DNA Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
Applied DNA Sciences Regains Nasdaq Minimum Bid Price Requirement
Banned Chinese cotton found in 19% of US retailers' merchandise, study shows
Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action APDN
  4. Actualités Applied DNA Sciences, Inc.
  5. Autres langues